Bluejay Diagnostics Stock Performance
| BJDX Stock | USD 3.82 0.37 8.83% |
On a scale of 0 to 100, Bluejay Diagnostics holds a performance score of 4. The firm shows a Beta (market volatility) of 0.9, which signifies possible diversification benefits within a given portfolio. Bluejay Diagnostics returns are very sensitive to returns on the market. As the market goes up or down, Bluejay Diagnostics is expected to follow. Please check Bluejay Diagnostics' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Bluejay Diagnostics' price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bluejay Diagnostics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile fundamental indicators, Bluejay Diagnostics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 6.08 | Five Day Return (0.24) | Year To Date Return (8.52) | Ten Year Return (99.99) | All Time Return (99.99) |
Last Split Factor 1:50 | Last Split Date 2024-11-18 |
1 | Acquisition by Dey Svetlana of 10000 shares of Bluejay Diagnostics at 0.44 subject to Rule 16b-3 | 12/26/2024 |
2 | SABBY MANAGEMENT, LLC Acquires Additional Shares in Bluejay Diag - GuruFocus.com | 01/03/2025 |
3 | Acquisition by Gemignani Gary G of 2500 shares of Bluejay Diagnostics subject to Rule 16b-3 | 01/10/2025 |
4 | Sensus leads med-tech stock rebound in 2024, year closes with modest sector gain - BioWorld Online | 01/23/2025 |
5 | Acquisition by Gemignani Gary G of 25000 shares of Bluejay Diagnostics at 2.72 subject to Rule 16b-3 | 02/12/2025 |
6 | Short Interest in Bluejay Diagnostics, Inc. Expands By 5.1 | 02/19/2025 |
7 | Acquisition by Zeidman Fred S of 27500 shares of Bluejay Diagnostics at 0.44 subject to Rule 16b-3 | 03/07/2025 |
8 | 12 Health Care Stocks Moving In Thursdays After-Market Session - Benzinga India | 03/20/2025 |
| Begin Period Cash Flow | 10.1 M |
Bluejay |
Bluejay Diagnostics Relative Risk vs. Return Landscape
If you would invest 380.00 in Bluejay Diagnostics on December 24, 2024 and sell it today you would earn a total of 39.00 from holding Bluejay Diagnostics or generate 10.26% return on investment over 90 days. Bluejay Diagnostics is currently generating 0.4034% in daily expected returns and assumes 7.0876% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of stocks are less volatile than Bluejay, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bluejay Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bluejay Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bluejay Diagnostics, and traders can use it to determine the average amount a Bluejay Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0569
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BJDX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.09 actual daily | 63 63% of assets are less volatile |
Expected Return
| 0.4 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Bluejay Diagnostics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bluejay Diagnostics by adding it to a well-diversified portfolio.
Bluejay Diagnostics Fundamentals Growth
Bluejay Stock prices reflect investors' perceptions of the future prospects and financial health of Bluejay Diagnostics, and Bluejay Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bluejay Stock performance.
| Return On Equity | -1.39 | ||||
| Return On Asset | -0.61 | ||||
| Current Valuation | (3.2 M) | ||||
| Shares Outstanding | 552.85 K | ||||
| Price To Book | 0.32 X | ||||
| Price To Sales | 54.99 X | ||||
| Gross Profit | 48.91 K | ||||
| EBITDA | (9.17 M) | ||||
| Net Income | (9.95 M) | ||||
| Cash And Equivalents | 15.34 M | ||||
| Cash Per Share | 0.76 X | ||||
| Total Debt | 352.98 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 17.41 X | ||||
| Book Value Per Share | 20.09 X | ||||
| Cash Flow From Operations | (8.31 M) | ||||
| Earnings Per Share | (804.00) X | ||||
| Market Capitalization | 2.32 M | ||||
| Total Asset | 4.87 M | ||||
| Retained Earnings | (26.95 M) | ||||
| Working Capital | 1.45 M | ||||
About Bluejay Diagnostics Performance
Evaluating Bluejay Diagnostics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Bluejay Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bluejay Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 226.56 | 281.78 | |
| Return On Tangible Assets | (2.35) | (2.23) | |
| Return On Capital Employed | (3.83) | (3.64) | |
| Return On Assets | (2.35) | (2.23) | |
| Return On Equity | (3.95) | (3.76) |
Things to note about Bluejay Diagnostics performance evaluation
Checking the ongoing alerts about Bluejay Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bluejay Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bluejay Diagnostics had very high historical volatility over the last 90 days | |
| Bluejay Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.95 M) with profit before overhead, payroll, taxes, and interest of 48.91 K. | |
| Bluejay Diagnostics currently holds about 15.34 M in cash with (8.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Bluejay Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: 12 Health Care Stocks Moving In Thursdays After-Market Session - Benzinga India |
- Analyzing Bluejay Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bluejay Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Bluejay Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bluejay Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bluejay Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bluejay Diagnostics' stock. These opinions can provide insight into Bluejay Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.